| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
104 Activity against human cytomegalovirus, cytotoxicity and mode of action of a non-nucleoside pyrrolo[2,3-d]pyrimidine
|
|
|
1994
|
|
S |
p. 91-
1 p.
|
artikel
|
| 2 |
112 Activity of azidothymidine (AZT) in combination with several antiviral nucleosides against varicella zoster virus (VZV) replication In vitro
|
|
|
1994
|
|
S |
p. 95-
1 p.
|
artikel
|
| 3 |
69 Activity of famciclovir and penciclovir in HSV-infected animals: A review
|
|
|
1994
|
|
S |
p. 72-
1 p.
|
artikel
|
| 4 |
70 A double-blind, placebo (PLB)-controlled trial of the effect of chronically administered oral famciclovir (FCV; BRL 42810) on sperm production in men with recurrent genital herpes (RGH) infection
|
|
|
1994
|
|
S |
p. 72-
1 p.
|
artikel
|
| 5 |
Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets
|
Garg, Sanjay
|
|
2010
|
|
S |
p. S19-S29
11 p.
|
artikel
|
| 6 |
Advances in microbicide vaginal rings
|
Malcolm, R. Karl
|
|
2010
|
|
S |
p. S30-S39
10 p.
|
artikel
|
| 7 |
173 An economical MTT-based in vitro assay system for bovine viral diarrhea virus (BVDV): A pestivirus in the family of flaviviridae
|
|
|
1994
|
|
S |
p. 128-
1 p.
|
artikel
|
| 8 |
137 Animal models of herpes family viral retinitis
|
|
|
1994
|
|
S |
p. 108-
1 p.
|
artikel
|
| 9 |
Antibody-based concepts for multipurpose prevention technologies
|
Whaley, Kevin J.
|
|
2013
|
|
S |
p. S48-S53
6 p.
|
artikel
|
| 10 |
130 Antiherpes effect of dextran sulphate combined with acyclovir in vitro and in vivo
|
|
|
1994
|
|
S |
p. 104-
1 p.
|
artikel
|
| 11 |
106 Anti-human cytomegalovirus (HCMV) activity of sulfonated anthraquinones
|
|
|
1994
|
|
S |
p. 92-
1 p.
|
artikel
|
| 12 |
184 Anti-influenza virus activity of 4-guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid in vitro
|
|
|
1994
|
|
S |
p. 133-
1 p.
|
artikel
|
| 13 |
37 Antiretroviral activity and selective cytotoxicity of lithium gamma-linolenic acid (LiGLA)
|
|
|
1994
|
|
S |
p. 55-
1 p.
|
artikel
|
| 14 |
36 Antiretroviral activity of N-α-acetyl-nona-D arginine amide acetate (ALX40-4C)
|
|
|
1994
|
|
S |
p. 54-
1 p.
|
artikel
|
| 15 |
56 Antiretroviral efficacy and pharmacokinetics of ester prodrugs of 9-(2-phosphonylmethoxy-ethyl) adenine (PMEA)
|
|
|
1994
|
|
S |
p. 64-
1 p.
|
artikel
|
| 16 |
180 Antisense inhibition of respiratory syncytial virus replication
|
|
|
1994
|
|
S |
p. 131-
1 p.
|
artikel
|
| 17 |
66 Antisense oligonucleotides against BZLF-1 inhibit induction of the productive replication of EBV
|
|
|
1994
|
|
S |
p. 70-
1 p.
|
artikel
|
| 18 |
164 Antiviral action of glutathione: Study on the mechanism
|
|
|
1994
|
|
S |
p. 123-
1 p.
|
artikel
|
| 19 |
91 Antiviral activity and mode of action of a sulfated galactan from Pterocladia capillaceae
|
|
|
1994
|
|
S |
p. 84-
1 p.
|
artikel
|
| 20 |
177 Antiviral activity of 1-methylascorbigen against bynyaviral infections (in experimental)
|
|
|
1994
|
|
S |
p. 130-
1 p.
|
artikel
|
| 21 |
188 Antiviral activity of mizoribine (4-carbamyl-1-B-D-ribofuranosylimidazolium-5-olate) against ortho- and paramyxoviruses
|
|
|
1994
|
|
S |
p. 135-
1 p.
|
artikel
|
| 22 |
82 Antiviral activity of penciclovir, a novel antiherpesvirus compound, against duck hepatitis B virus in vitro
|
|
|
1994
|
|
S |
p. 79-
1 p.
|
artikel
|
| 23 |
172 Antiviral activity of proteolytic inhibitor ambenum (para-aminomethylbenzoic acid). V.P. Lozitsky, A.S.
|
|
|
1994
|
|
S |
p. 127-
1 p.
|
artikel
|
| 24 |
122 Antiviral activity of triciribine and triciribine monophosphate against human herpesvirus type 6
|
|
|
1994
|
|
S |
p. 100-
1 p.
|
artikel
|
| 25 |
163 Antiviral drug izatizon restores interferon action. The enlargement of interferon antiviral activity spectrum
|
|
|
1994
|
|
S |
p. 123-
1 p.
|
artikel
|
| 26 |
199 Antiviral effect of BC30 in experimental influenza virus infection in white mice
|
|
|
1994
|
|
S |
p. 141-
1 p.
|
artikel
|
| 27 |
11 Antiviral properties of BMS 182,193, an aminoalcohol inhibitor of HIV protease
|
|
|
1994
|
|
S |
p. 41-
1 p.
|
artikel
|
| 28 |
29 Antiviral properties of BMS 182,193, an aminoalcohol inhibitor of HIV protease
|
|
|
1994
|
|
S |
p. 51-
1 p.
|
artikel
|
| 29 |
Antiviral research branch enteric diseases branch national institute of allergy and infections diseases national institutes of health
|
|
|
1994
|
|
S |
p. 148-149
2 p.
|
artikel
|
| 30 |
86 A phase I/II open-label study to assess the safety, pharmacokinetic profile, and preliminary antiviral effects of ost-577 (a human anti-hepatitis b surface antigen monoclonal antibody) administered to patients who are persistently hepatitis b antigen seropositive
|
|
|
1994
|
|
S |
p. 81-
1 p.
|
artikel
|
| 31 |
196 Aprotinin treatment of influenza b virus bronchopneumonia of mice
|
|
|
1994
|
|
S |
p. 139-
1 p.
|
artikel
|
| 32 |
166 A rapid and high capacity In vitro antiviral assay for hepatitis B virus using quantitative polymerase chain reaction (PCR)
|
|
|
1994
|
|
S |
p. 124-
1 p.
|
artikel
|
| 33 |
60 A stromal cell line from LP-BM5 infected long-termm bone marrow cell cultures (LTBMC) inhibits hematopoiesis In Vitro
|
|
|
1994
|
|
S |
p. 66-
1 p.
|
artikel
|
| 34 |
3 A structural model for HIV-1 integrase
|
|
|
1994
|
|
S |
p. 36-
1 p.
|
artikel
|
| 35 |
Author index
|
|
|
1994
|
|
S |
p. 145-147
3 p.
|
artikel
|
| 36 |
79 A variant of echovirus 12 that requires the selective antiviral inhibitor rhodanine for replication
|
|
|
1994
|
|
S |
p. 78-
1 p.
|
artikel
|
| 37 |
182 A wide spectrum of antiviral activity of a new syntetic inhibitor of proteolysis
|
|
|
1994
|
|
S |
p. 132-
1 p.
|
artikel
|
| 38 |
143b Antiviral drug resistance mutations in HIV-1 reverse transcriptase occur in specific RNA structural regions
|
|
|
1994
|
|
S |
p. 111-
1 p.
|
artikel
|
| 39 |
50 Biochemical analysis of human immunodeficiency virus type-1 reverse transcriptase with mutations at methione 184 in the highly conserved YMDD region: Mechanism for 1-β-L nucleoside drug resistance
|
|
|
1994
|
|
S |
p. 61-
1 p.
|
artikel
|
| 40 |
38 Biological and biochemical anti-HIV activity of a phosphorothioate G-quartet (TTGGGGTT)
|
|
|
1994
|
|
S |
p. 55-
1 p.
|
artikel
|
| 41 |
176 Bone marrow mononuclear cells producing IL-1 and IL-2 inhibited by HBV in vitro and in vivo
|
|
|
1994
|
|
S |
p. 129-
1 p.
|
artikel
|
| 42 |
147 Boron modified peptide: A novel dissociative inhibitor of HIV-1 protease
|
|
|
1994
|
|
S |
p. 114-
1 p.
|
artikel
|
| 43 |
153 Brain delivery of 2′-F-ara-ddl by utilizing xanthine oxidase biotransformation system
|
|
|
1994
|
|
S |
p. 117-
1 p.
|
artikel
|
| 44 |
90 Carboxy-terminal peptidomimetics of the herpes simplex virus ribonucleotide reductase small subunit inhibit viral replication and potentiate the antiviral activity of acyclovir
|
|
|
1994
|
|
S |
p. 84-
1 p.
|
artikel
|
| 45 |
Clinical evaluation of microbicide formulations
|
Morrow, Kathleen M.
|
|
2010
|
|
S |
p. S40-S46
7 p.
|
artikel
|
| 46 |
15 Clinical trials of (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (HPMPC)
|
|
|
1994
|
|
S |
p. 43-
1 p.
|
artikel
|
| 47 |
194 Combinated antiviral effect of some bacterial and synthetic inhibitors
|
|
|
1994
|
|
S |
p. 138-
1 p.
|
artikel
|
| 48 |
192 Combination effects of picornavirus replication inhibitors
|
|
|
1994
|
|
S |
p. 137-
1 p.
|
artikel
|
| 49 |
197 Combined effect of an antioxidative agent (ionol) and rimantadine on experimental influenza virus A(H3N2) infection in mice
|
|
|
1994
|
|
S |
p. 140-
1 p.
|
artikel
|
| 50 |
Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
|
Friend, David R.
|
|
2010
|
|
S |
p. S47-S54
8 p.
|
artikel
|
| 51 |
121 Comparative activity of penciclovir and acyclovir against epstein-barr virus
|
|
|
1994
|
|
S |
p. 99-
1 p.
|
artikel
|
| 52 |
68 Comparative activity of penciclovir and acyclovir against herpes simplex virus type 2 in cell culture
|
|
|
1994
|
|
S |
p. 71-
1 p.
|
artikel
|
| 53 |
111 Comparative activity of selected antiviral compounds on In vitro replication of varicella zoster virus clinical strains
|
|
|
1994
|
|
S |
p. 94-
1 p.
|
artikel
|
| 54 |
93 Comparative antivirial activity of compounds against thymidine-kinase deficient acyclovir resistant mutants of herpes simplex virus type 1
|
|
|
1994
|
|
S |
p. 85-
1 p.
|
artikel
|
| 55 |
39 Comparative biological and biochemical evaluation of a diverse group of nonnucleoside reverse transcriptase inhibitors
|
|
|
1994
|
|
S |
p. 56-
1 p.
|
artikel
|
| 56 |
12 Comparison of anti-HSV activity and metabolism of acyclic nucleotide analogs
|
|
|
1994
|
|
S |
p. 41-
1 p.
|
artikel
|
| 57 |
42 Comparison of antiretroviral drug combinations in a murine leukemia virus (MuLV) model
|
|
|
1994
|
|
S |
p. 57-
1 p.
|
artikel
|
| 58 |
99 Comparison of penciclovir with acyclovir for treatment of severe herpes simplex virus infections of mice
|
|
|
1994
|
|
S |
p. 88-
1 p.
|
artikel
|
| 59 |
113 Comparison of selective indexes of anti-varicella-zoster virus activity of nucleoside analogues
|
|
|
1994
|
|
S |
p. 95-
1 p.
|
artikel
|
| 60 |
47 Comparison of the conformations of the 5′-triphosphates of zidovudine® (AZT) and thymidine bound to HIV-1 reverse transcriptase
|
|
|
1994
|
|
S |
p. 60-
1 p.
|
artikel
|
| 61 |
72 Comparison of topical capsaicin and parenteral acyclovir in the treatment of primary genital herpes: Effect of treatment on the subsequent development of recurrent disease
|
|
|
1994
|
|
S |
p. 73-
1 p.
|
artikel
|
| 62 |
Conference banquet
|
|
|
1994
|
|
S |
p. 6-
1 p.
|
artikel
|
| 63 |
Conference committees
|
|
|
1994
|
|
S |
p. 3-4
2 p.
|
artikel
|
| 64 |
Corporate sponsors
|
|
|
1994
|
|
S |
p. 5-6
2 p.
|
artikel
|
| 65 |
108 Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits HCMV at or near the stage of DNA replication
|
|
|
1994
|
|
S |
p. 93-
1 p.
|
artikel
|
| 66 |
135 Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses
|
|
|
1994
|
|
S |
p. 107-
1 p.
|
artikel
|
| 67 |
136 Cyclocreatine improves the structural integrity of the retina in human cytomegalovirus-induced chorioretinitis in the rabbit model
|
|
|
1994
|
|
S |
p. 107-
1 p.
|
artikel
|
| 68 |
22 Cytosolic delivery of anti-hiv nucleoside monophosphates having enzyme-labile transient phosphate protecting groups
|
|
|
1994
|
|
S |
p. 47-
1 p.
|
artikel
|
| 69 |
Designing a multipurpose technology for acceptability and adherence
|
Tolley, Elizabeth E.
|
|
2013
|
|
S |
p. S54-S59
6 p.
|
artikel
|
| 70 |
179 Determination of functional domains in the influenza virus polymerase through site-directed mutagenesis and transient expression
|
|
|
1994
|
|
S |
p. 131-
1 p.
|
artikel
|
| 71 |
Developmental therapeutics branch division of AIDS national institute of allergy and infectious diseases national institutes of health
|
|
|
1994
|
|
S |
p. 149-150
2 p.
|
artikel
|
| 72 |
134 Development of a guinea pig model for determining the pharmacokinetics of antiviral agents
|
|
|
1994
|
|
S |
p. 106-
1 p.
|
artikel
|
| 73 |
150 Development of an In Vivo model of HIV latency and activation
|
|
|
1994
|
|
S |
p. 115-
1 p.
|
artikel
|
| 74 |
Development of dapivirine vaginal ring for HIV prevention
|
Devlin, Bríd
|
|
2013
|
|
S |
p. S3-S8
6 p.
|
artikel
|
| 75 |
85 Development of (−)-β-D-2,6-diaminopurine dioxolane as a potential antiviral agent
|
|
|
1994
|
|
S |
p. 81-
1 p.
|
artikel
|
| 76 |
34 Didanosine (DDI) and zidovudine (AZT) sensitivities of HIV-1 strains isolated from DDI-treated patients, and tested in a heLa-CD4 immunofluorescence focus assay (IFFA)
|
|
|
1994
|
|
S |
p. 53-
1 p.
|
artikel
|
| 77 |
146 Drug-induced cell mediated mechanism leading to resistance of HIV to AZT
|
|
|
1994
|
|
S |
p. 113-
1 p.
|
artikel
|
| 78 |
145 Drug-resistant HIV-1 mutants may undergo further mutations in their reverse transcriptase (RT) under continuous pressure of HIV-1-specific RT inhibitors
|
|
|
1994
|
|
S |
p. 113-
1 p.
|
artikel
|
| 79 |
Editorial Board
|
|
|
2010
|
|
S |
p. ii-
1 p.
|
artikel
|
| 80 |
Editorial Board
|
|
|
1994
|
|
S |
p. ii-
1 p.
|
artikel
|
| 81 |
61 Effect of antiviral nucleoside analogs on human polymerases and mitochondrial DNA synthesis
|
|
|
1994
|
|
S |
p. 67-
1 p.
|
artikel
|
| 82 |
165 Effect of fialuridine (FIAU) on the in vitro replication of mitochondrial DNA in human T cells and in human hepatoblastoma cells
|
|
|
1994
|
|
S |
p. 124-
1 p.
|
artikel
|
| 83 |
97 Effect of human recombinant and recombinant hybrid alpha-interferons on the replication of herpes simplex virus type 1 in human fibroblast and neuroblastoma cells
|
|
|
1994
|
|
S |
p. 87-
1 p.
|
artikel
|
| 84 |
178 Effect of ribavirin on SSPE virus infection in hamsters
|
|
|
1994
|
|
S |
p. 130-
1 p.
|
artikel
|
| 85 |
131 2Effect of the gamma interferon (r) alone and in combination 2on O 2the replication of the Human cytomegalovirus
|
|
|
1994
|
|
S |
p. 104-
1 p.
|
artikel
|
| 86 |
96 Effect of zn-complexes on HSV-2 infection in vitro
|
|
|
1994
|
|
S |
p. 87-
1 p.
|
artikel
|
| 87 |
140 Effects of combinations of HIV-1 specific RT inhibitors with complementary resistance profiles on the time and type of drug-resistant HIV-1 development
|
|
|
1994
|
|
S |
p. 109-
1 p.
|
artikel
|
| 88 |
40 Effects of HIV-inhibitory compounds on the production of virus from chronically and latently infected cell lines
|
|
|
1994
|
|
S |
p. 56-
1 p.
|
artikel
|
| 89 |
84 Effects of IFNα on HBV gene expression in transgenic mice
|
|
|
1994
|
|
S |
p. 80-
1 p.
|
artikel
|
| 90 |
71 Efficacy of famciclovir on herpes zoster rash resolution and post-herpetic neuralgia
|
|
|
1994
|
|
S |
p. 73-
1 p.
|
artikel
|
| 91 |
Electrospun fibers for vaginal anti-HIV drug delivery
|
Blakney, Anna K.
|
|
2013
|
|
S |
p. S9-S16
8 p.
|
artikel
|
| 92 |
9 Enantiomeric DDC derivatives are potent inhibitors of HIV replication in cell cultures
|
|
|
1994
|
|
S |
p. 39-
1 p.
|
artikel
|
| 93 |
101 Evaluation of retinal toxicity and efficacy of a phosphorothioate antisense against herpes retinitis in a rabbit model
|
|
|
1994
|
|
S |
p. 89-
1 p.
|
artikel
|
| 94 |
17 Evaluation of retinal toxicity of the anti-CMV compound 2-amino-7-[(1,3-dihydroxy-2-propoxy) methyl] purine
|
|
|
1994
|
|
S |
p. 44-
1 p.
|
artikel
|
| 95 |
120 Expression and functional characterization of epstein-barr virus DNA polymerase in insect cells infected with a recombinant baculovirus
|
|
|
1994
|
|
S |
p. 99-
1 p.
|
artikel
|
| 96 |
148 Factors other than reverse transcriptase contribute to resistance of feline immunodeficiency virus to reverse transcriptase-targeted antivirals
|
|
|
1994
|
|
S |
p. 114-
1 p.
|
artikel
|
| 97 |
118 Famciclovir: Confirmed efficacy of 250mg t.i.d for the treatment of herpes zoster (HZ) infection. M.
|
|
|
1994
|
|
S |
p. 98-
1 p.
|
artikel
|
| 98 |
119 Famciclovir in the treatment of herpes zoster (HZ) infection
|
|
|
1994
|
|
S |
p. 98-
1 p.
|
artikel
|
| 99 |
185 First phase of clinical trials new antiviral drug-viramid
|
|
|
1994
|
|
S |
p. 134-
1 p.
|
artikel
|
| 100 |
43 Ganciclovir does not antagonize the anti-human immunodeficiency virus activity of AZT in A3.01 cells in vitro
|
|
|
1994
|
|
S |
p. 58-
1 p.
|
artikel
|
| 101 |
117 GR95168X (chiral carbocyclic BVdU) is highly effective against simian varicella virus infections of African green monkeys
|
|
|
1994
|
|
S |
p. 97-
1 p.
|
artikel
|
| 102 |
204 Guinea pig as a model for study of marburg virus interraction with mononuclear phagocytes
|
|
|
1994
|
|
S |
p. 143-
1 p.
|
artikel
|
| 103 |
89 5-Heteroaromatic substituted 2′-deoxyuridines as anti-HSV-1 agents: Synthesis, antiviral activity and structure-activity relationship
|
|
|
1994
|
|
S |
p. 83-
1 p.
|
artikel
|
| 104 |
116 Highly bioavailable prodrugs of the potent anti-varicella zoster virus agent, 1-(β-D-arabinofuranosyl)-5-prop-1-ynyluracil (882C87)
|
|
|
1994
|
|
S |
p. 97-
1 p.
|
artikel
|
| 105 |
152 HIV-infected Hu-PBMC-SCID mice as a model for antiviral drug development
|
|
|
1994
|
|
S |
p. 116-
1 p.
|
artikel
|
| 106 |
53 Hydroxyurea inhibits HIV-1 replication by inducing low dNTP levels. A cellular enzyme as a target to inhibit HIV-1
|
|
|
1994
|
|
S |
p. 63-
1 p.
|
artikel
|
| 107 |
186 Identification of a novel class of oligonucleotide inhibitors of the influenza viral polymerase
|
|
|
1994
|
|
S |
p. 134-
1 p.
|
artikel
|
| 108 |
144 Identification of distinct subgroups of nonnucleoside reverse transcriptase inhibitors defined by cross-resistance phenotypes of drug-resistant virus isolates
|
|
|
1994
|
|
S |
p. 112-
1 p.
|
artikel
|
| 109 |
67 Identification of the specific serine residue at the active site of the herpes simplex virus type 1 protease
|
|
|
1994
|
|
S |
p. 71-
1 p.
|
artikel
|
| 110 |
98 Immunoprophylactic strategies for prevention of genital herpes simplex virus infections
|
|
|
1994
|
|
S |
p. 88-
1 p.
|
artikel
|
| 111 |
74 Increased bioavailability of acyclovir from oral valaciclovir in healthy volunteers
|
|
|
1994
|
|
S |
p. 74-
1 p.
|
artikel
|
| 112 |
83 Inhibition of duck hepatitis B virus DNA polymerase by the triphosphate of fialuridine
|
|
|
1994
|
|
S |
p. 80-
1 p.
|
artikel
|
| 113 |
170 Inhibition of duck hepatitis B virus replication by N-(phosphonoacetyl)-L-aspartate (PALA; USNUS-08-0) In vitro
|
|
|
1994
|
|
S |
p. 126-
1 p.
|
artikel
|
| 114 |
167 Inhibition of HBV polymerase by nucleotide analogs: Differential activity of enantiomers
|
|
|
1994
|
|
S |
p. 125-
1 p.
|
artikel
|
| 115 |
80 Inhibition of Hepatitis B virus replication in vitro by Antisense oligonucleotides
|
|
|
1994
|
|
S |
p. 78-
1 p.
|
artikel
|
| 116 |
92 Inhibition of herpes simplex type 1 by meliacine, a peptide of plant origin
|
|
|
1994
|
|
S |
p. 85-
1 p.
|
artikel
|
| 117 |
102 Inhibition of herpes simplex virus type 1 replication by a hybrid E. coli heat-labile enterotoxin B subunit
|
|
|
1994
|
|
S |
p. 90-
1 p.
|
artikel
|
| 118 |
51 Inhibition of HIV-1 replication by SDZ NIM 811, a non-immunosuppressive cyclosporin a analog: Mode of action studies
|
|
|
1994
|
|
S |
p. 62-
1 p.
|
artikel
|
| 119 |
190 Inhibition of influenza virus reproduction by combined preparations of medicinal plants
|
|
|
1994
|
|
S |
p. 136-
1 p.
|
artikel
|
| 120 |
183 Inhibition of respiratory syncytial virus replication In vitro by N-butyldeoxynojirimycin (NB-DNJ/SC-48334)
|
|
|
1994
|
|
S |
p. 133-
1 p.
|
artikel
|
| 121 |
200 Inhibition of virus infections of mice by the combination of aerosolized MnSOD and ribavirin
|
|
|
1994
|
|
S |
p. 141-
1 p.
|
artikel
|
| 122 |
Inside Back Cover: Notes to Authors
|
|
|
2013
|
|
S |
p. IBC-
1 p.
|
artikel
|
| 123 |
Introduction to sponsors
|
|
|
1994
|
|
S |
p. 5-
1 p.
|
artikel
|
| 124 |
95In vitro activity of the herpes simplex virus type 1 and cytomegalovirus proteases with peptide substrates
|
|
|
1994
|
|
S |
p. 86-
1 p.
|
artikel
|
| 125 |
88 In vitro and In vivo Activity of the N-7 isomeric acyclic nucleoside analogue 2242 against an acyclovir/foscarnet-resistant herpes simplex virus type 1 clinical isolate
|
|
|
1994
|
|
S |
p. 83-
1 p.
|
artikel
|
| 126 |
198 In Vitro and In Vivo inhibition of ortho- and paramyxovirus infection by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion
|
|
|
1994
|
|
S |
p. 140-
1 p.
|
artikel
|
| 127 |
123In vitro and In vivo metabolism of HOE 961
|
|
|
1994
|
|
S |
p. 100-
1 p.
|
artikel
|
| 128 |
78 In vitro anti-myxovirus activity of polyoxometalates
|
|
|
1994
|
|
S |
p. 77-
1 p.
|
artikel
|
| 129 |
94 In vitro selection of an herpes simplex virus type 1 (HSV-1) mutant resistant to the N7-isomeric acyclic nucleoside analogue 2242
|
|
|
1994
|
|
S |
p. 86-
1 p.
|
artikel
|
| 130 |
16 In vivo anti-herpesvirus activity of the N7-isomeric acyclic nucleoside analogue 2242 and its prodrug HOE 961
|
|
|
1994
|
|
S |
p. 43-
1 p.
|
artikel
|
| 131 |
45 Isolation and characterization of an HIV-1 variant with reduced sensitivity to an aminoalcohol protease inhibitor
|
|
|
1994
|
|
S |
p. 59-
1 p.
|
artikel
|
| 132 |
6 Kinase by-pass: A new strategy for antiviral drug discovery
|
|
|
1994
|
|
S |
p. 38-
1 p.
|
artikel
|
| 133 |
4 L-735, 524: An orally bioavailable human immunodeficiency virus type 1 protease inhibitor
|
|
|
1994
|
|
S |
p. 37-
1 p.
|
artikel
|
| 134 |
162 β-L-2′,3′-Dideoxycytidine (L-DDC) and its 5-fluoro derivative (L-FDDC) are potent inhibitors of hepatitis B virus (HBV)
|
|
|
1994
|
|
S |
p. 122-
1 p.
|
artikel
|
| 135 |
Lessons from reproductive health to inform multipurpose prevention technologies: Don’t reinvent the wheel
|
Brady, Martha
|
|
2013
|
|
S |
p. S25-S31
7 p.
|
artikel
|
| 136 |
57 Lipophilic phosphorus prodrugs for the antiviral agent PMEA
|
|
|
1994
|
|
S |
p. 65-
1 p.
|
artikel
|
| 137 |
48 Local perturbation of recombinant HIV-1 reverse transcriptase by urea occurs prior to global denaturation
|
|
|
1994
|
|
S |
p. 60-
1 p.
|
artikel
|
| 138 |
149 Long term suppression of human immunodeficiency virus type 1 activity in vitro by guanosine/thymidine oligonucleotides (GTOs)
|
|
|
1994
|
|
S |
p. 115-
1 p.
|
artikel
|
| 139 |
62 Mixed infection of lymphoid cells, induced with epstain-barr virus, adenoviruses, HIV, HTLV-I as a model for screening antivirus substances
|
|
|
1994
|
|
S |
p. 67-
1 p.
|
artikel
|
| 140 |
139 MKC-442, a highly potent and specific inhibitor of HIV-1
|
|
|
1994
|
|
S |
p. 109-
1 p.
|
artikel
|
| 141 |
Multipurpose prevention technologies: Products in development
|
Friend, David R.
|
|
2013
|
|
S |
p. S39-S47
9 p.
|
artikel
|
| 142 |
75 n-Docosanol cream is an effective topical treatment of recurrent herpes labialis
|
|
|
1994
|
|
S |
p. 75-
1 p.
|
artikel
|
| 143 |
129 New micromethod for titration of DNA viruses encoding thymidine kinase
|
|
|
1994
|
|
S |
p. 103-
1 p.
|
artikel
|
| 144 |
1 New opportunities for gene therapy against HIV
|
|
|
1994
|
|
S |
p. 35-
1 p.
|
artikel
|
| 145 |
Notes to Authors
|
|
|
2010
|
|
S |
p. CO3-
1 p.
|
artikel
|
| 146 |
5 Novel aminoalcohol inhibitors of HIV protease. Design, synthesis, and characterization
|
|
|
1994
|
|
S |
p. 37-
1 p.
|
artikel
|
| 147 |
Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines
|
Whaley, Kevin J.
|
|
2010
|
|
S |
p. S55-S66
12 p.
|
artikel
|
| 148 |
7 Novel chiral isomeric nucleosides and nucleotides: Synthesis, enzymology and anti-HIV activity
|
|
|
1994
|
|
S |
p. 38-
1 p.
|
artikel
|
| 149 |
168 Novel ether lipid analogs of platelet activating factor with anti-hepatitis B virus activity
|
|
|
1994
|
|
S |
p. 125-
1 p.
|
artikel
|
| 150 |
21 Nucleoside derivatives of 2-mercapto-5,6-dichlorobenzimidazole: Synthesis and antiviral evaluation
|
|
|
1994
|
|
S |
p. 47-
1 p.
|
artikel
|
| 151 |
59 2′5′ Oligoadenylate synthetase and effects of interferon on retrovirus-producing murine lymphoma cells
|
|
|
1994
|
|
S |
p. 66-
1 p.
|
artikel
|
| 152 |
55 Optimization of the reverse transcriptase assay for the detection of viral burden in mice infected with rauscher murine leukemia virus
|
|
|
1994
|
|
S |
p. 64-
1 p.
|
artikel
|
| 153 |
Oral session II: Herpesvirus infections I
|
|
|
1994
|
|
S |
p. 8-9
2 p.
|
artikel
|
| 154 |
Oral session III: Herpesvirus infections II
|
|
|
1994
|
|
S |
p. 16-17
2 p.
|
artikel
|
| 155 |
Oral session I: Retrovirus infections I
|
|
|
1994
|
|
S |
p. 7-8
2 p.
|
artikel
|
| 156 |
Oral session IV: Herpesvirus infections III-retrovirus infections II
|
|
|
1994
|
|
S |
p. 25-26
2 p.
|
artikel
|
| 157 |
Oral session IV: Respiratory and hepatitis virus infections
|
|
|
1994
|
|
S |
p. 17-18
2 p.
|
artikel
|
| 158 |
Oral session VIII: Minisymposium - molecular targets/gene expression
|
|
|
1994
|
|
S |
p. 34-
1 p.
|
artikel
|
| 159 |
Oral session VII: Retrovirus infections III
|
|
|
1994
|
|
S |
p. 26-27
2 p.
|
artikel
|
| 160 |
Oral session V: Minisymposium - viral pathogenesis: Implications for antiviral therapy
|
|
|
1994
|
|
S |
p. 24-
1 p.
|
artikel
|
| 161 |
19 Oral vs intravenous ganciclovir (GCV) as maintenance treatment of newly diagnosed cytomegalovirus retinitis (CMVR) in AIDS
|
|
|
1994
|
|
S |
p. 45-
1 p.
|
artikel
|
| 162 |
18 Pharmacokinetics and bioavailability of cygalovir (BMS-180194) in asymptomatic HIV- and CMV-seropositive volunteers
|
|
|
1994
|
|
S |
p. 44-
1 p.
|
artikel
|
| 163 |
127 Pharmacokinetics and metabolism of systemic administration of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-Iodo-2,4(1H,3H)-pyrimidinedione (FIAU) in hartley guinea pigs
|
|
|
1994
|
|
S |
p. 102-
1 p.
|
artikel
|
| 164 |
159 Pharmacologically active amines as in vitro inhibitors of Junin virus
|
|
|
1994
|
|
S |
p. 121-
1 p.
|
artikel
|
| 165 |
124 Pharmcokinetics and therapeutic efficacy of prodrugs of N7-isomeric acyclic nucleoside analogues in animals
|
|
|
1994
|
|
S |
p. 101-
1 p.
|
artikel
|
| 166 |
109 Phase I trial of a new anti-cytomegalovirus agent, (s)-1[3-hydroxy-2-(phosphonyl-methoxy)propyl]cytosine (HPMPC), in HIV-infected volunteers
|
|
|
1994
|
|
S |
p. 93-
1 p.
|
artikel
|
| 167 |
13 Phosphonate derivatives of ganciclovir and acyclovir inhibit murine cytomegalovirus (MCMV) infections in cell culture and in mice
|
|
|
1994
|
|
S |
p. 42-
1 p.
|
artikel
|
| 168 |
141 Phosphorylation and subcellular distribution of HIV-1 MA protein
|
|
|
1994
|
|
S |
p. 110-
1 p.
|
artikel
|
| 169 |
Poster session II: Herpesvirus infections
|
|
|
1994
|
|
S |
p. 18-23
6 p.
|
artikel
|
| 170 |
Poster session III: Hepadnavirus, respiratory virus, and other infections
|
|
|
1994
|
|
S |
p. 27-33
7 p.
|
artikel
|
| 171 |
Poster session I: Retroviruses
|
|
|
1994
|
|
S |
p. 10-15
6 p.
|
artikel
|
| 172 |
32 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Structure activity relationships
|
|
|
1994
|
|
S |
p. 52-
1 p.
|
artikel
|
| 173 |
30 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Synthesis and effects of macrocyclic ring size
|
|
|
1994
|
|
S |
p. 51-
1 p.
|
artikel
|
| 174 |
31 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Synthesis and effects of substitution at the aromatic linker
|
|
|
1994
|
|
S |
p. 52-
1 p.
|
artikel
|
| 175 |
28 Potent inhibitors of HIV protease: P2 and P3 extended analogs of BMS-182,193
|
|
|
1994
|
|
S |
p. 50-
1 p.
|
artikel
|
| 176 |
Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers
|
Doncel, Gustavo F.
|
|
2010
|
|
S |
p. S10-S18
9 p.
|
artikel
|
| 177 |
10 Preclinical evaluation of a phosphorothioate oligonucleotide with potent antiviral activity against human cytomegalovirus
|
|
|
1994
|
|
S |
p. 40-
1 p.
|
artikel
|
| 178 |
Prelim II: Editorial Board
|
|
|
2013
|
|
S |
p. ii-
1 p.
|
artikel
|
| 179 |
100 Pretreatment with topical capsaicin (0.25%) does not prevent UV light-induced reactivation of herpes labialis (HL)
|
|
|
1994
|
|
S |
p. 89-
1 p.
|
artikel
|
| 180 |
Preventing mucosal HIV transmission with topical microbicides: Challenges and opportunities
|
Hladik, Florian
|
|
2010
|
|
S |
p. S3-S9
7 p.
|
artikel
|
| 181 |
154 Priming of duck hepatitis B virus DNA replication: A viral function which is refractory to inhibition by triphosphates of dideoxynucleoside analogs
|
|
|
1994
|
|
S |
p. 118-
1 p.
|
artikel
|
| 182 |
Prioritizing multipurpose prevention technology development and investments using a target product profile
|
Romano, Joe
|
|
2013
|
|
S |
p. S32-S38
7 p.
|
artikel
|
| 183 |
Product Development Workshop 2013: HIV and Multipurpose Prevention Technologies
|
Friend, David R.
|
|
2013
|
|
S |
p. S1-S2
2 p.
|
artikel
|
| 184 |
133 Proliferative activity of VERO cells, infected with HSV-1 variants resistant to acyclovir and phosphonoacetic acid
|
|
|
1994
|
|
S |
p. 105-
1 p.
|
artikel
|
| 185 |
114 Prolonged activity of penciclovir in cell culture against varicella-zoster virus
|
|
|
1994
|
|
S |
p. 96-
1 p.
|
artikel
|
| 186 |
191 Protective effect of bacterial preparation CM in experimental influenza infection
|
|
|
1994
|
|
S |
p. 137-
1 p.
|
artikel
|
| 187 |
195 Proteolysis inhibitors influence on the interactions of influenza viruses with membranes of sensitive cells
|
|
|
1994
|
|
S |
p. 139-
1 p.
|
artikel
|
| 188 |
64 Rapid evaluation of experimental antiretroviral therapy by quantitative competitive polymerase chain reaction (QC-PCR) assessment of HIV-1 viral load in plasma
|
|
|
1994
|
|
S |
p. 68-
1 p.
|
artikel
|
| 189 |
49 Recombinant human immunodeficiency virus type-1 reverse transcriptase is conformationally heterogeneous
|
|
|
1994
|
|
S |
p. 61-
1 p.
|
artikel
|
| 190 |
Rectal pre-exposure prophylaxis (PrEP)
|
Rohan, Lisa C.
|
|
2013
|
|
S |
p. S17-S24
8 p.
|
artikel
|
| 191 |
142 Replication of HIV-1 and HSV-1 in macrophages: Comparative activity of acyclic nucleoside phosphonates in the presence or absence of cytokines enhancers of virus replication
|
|
|
1994
|
|
S |
p. 110-
1 p.
|
artikel
|
| 192 |
205 Role of nonspecific factors of immunity in treatment of experimental arenaviral hemorrhagic fever
|
|
|
1994
|
|
S |
p. 144-
1 p.
|
artikel
|
| 193 |
63 Salivary inhibition of HIV: Broad antiviral activity of salivary mucin and correlation of antiviral activity with the recovery of infectious virus
|
|
|
1994
|
|
S |
p. 68-
1 p.
|
artikel
|
| 194 |
Satellite symposium
|
|
|
1994
|
|
S |
p. 6-
1 p.
|
artikel
|
| 195 |
175 Seasonal changes in metabolism in the woodchuck hepatitis virus model affect the toxicity of the antiviral nucleoside analog FEAU
|
|
|
1994
|
|
S |
p. 129-
1 p.
|
artikel
|
| 196 |
35 Selective activity of triciribine against HIV-1 in acutely infected CEM-T4 cells
|
|
|
1994
|
|
S |
p. 54-
1 p.
|
artikel
|
| 197 |
132 Selective anti HSV-1 (TK− activity of 9-(2-hydrogenphosphonyl-hydroxyethoxymethyl) guanine and its combined effects with glycyrrhisine and ribavirine
|
|
|
1994
|
|
S |
p. 105-
1 p.
|
artikel
|
| 198 |
189 Selective inhibition of myxovirus replication by a novel series of cholesterol-naphthalenesulfonic acid hybrid molecules
|
|
|
1994
|
|
S |
p. 136-
1 p.
|
artikel
|
| 199 |
33 Selective inhibition of viral dna polymerases by the triphosphates of β-L-2′,3′-dideoxycytidine (β-L-DDC) and its 5-fluoro derivative (β-L-FDDC)
|
|
|
1994
|
|
S |
p. 53-
1 p.
|
artikel
|
| 200 |
52 Sequence comparison of different subpopulations of proviral and ‘viral’ HIV-1 reverse transcriptase from patients on long-term AZT treatment
|
|
|
1994
|
|
S |
p. 62-
1 p.
|
artikel
|
| 201 |
20 Short sequences of the matrix- and the capsid-protein of the Human Immunodeficiency Virus (HIV) influence viral assembly and inhibit production of infective particles
|
|
|
1994
|
|
S |
p. 46-
1 p.
|
artikel
|
| 202 |
201 Single dose efficacy of 2′-fluorodGuo in the mouse and ferret influenza models
|
|
|
1994
|
|
S |
p. 142-
1 p.
|
artikel
|
| 203 |
Social functions
|
|
|
1994
|
|
S |
p. 6-
1 p.
|
artikel
|
| 204 |
138 Stereoselective synthesis of novel antiviral nucleoside analogues
|
|
|
1994
|
|
S |
p. 108-
1 p.
|
artikel
|
| 205 |
105 Structure-activity relationships of non-nucleoside pyrrolopyrimidine analogs active against human cytomegalovirus
|
|
|
1994
|
|
S |
p. 91-
1 p.
|
artikel
|
| 206 |
171 Studies on some new biological properties of isoprinosine concerning its buffer capacity
|
|
|
1994
|
|
S |
p. 127-
1 p.
|
artikel
|
| 207 |
126 Studies on the In Vivo synthesis and In Vitro biochemical properties of penciclovir triphosphate
|
|
|
1994
|
|
S |
p. 102-
1 p.
|
artikel
|
| 208 |
157 Study of chinese herbal drugs against coxsackie B1, B3, B4 virus in cell culture
|
|
|
1994
|
|
S |
p. 120-
1 p.
|
artikel
|
| 209 |
158 Study of chinese herbal drugs against epidemic hemorrhagic fever virus in cell culture
|
|
|
1994
|
|
S |
p. 120-
1 p.
|
artikel
|
| 210 |
193 Study of Chinese herbal drugs against respiratory syncytial virus in cell cultures
|
|
|
1994
|
|
S |
p. 138-
1 p.
|
artikel
|
| 211 |
58 Superantigen toxic syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells: Implication of a new anti-HIV-1 assay In Vitro
|
|
|
1994
|
|
S |
p. 65-
1 p.
|
artikel
|
| 212 |
87 Syntheses and in vivo antiviral activity of prodrugs of an N7-isomeric acyclic nucleoside analogue
|
|
|
1994
|
|
S |
p. 82-
1 p.
|
artikel
|
| 213 |
26 Synthesis and anti-HIV activity of isonucleosides and acyclic nucleotides related to clitocine
|
|
|
1994
|
|
S |
p. 49-
1 p.
|
artikel
|
| 214 |
41 Synthesis and anti-HIV-1 activity of pyrrolobenzothiadiazepines
|
|
|
1994
|
|
S |
p. 57-
1 p.
|
artikel
|
| 215 |
155 Synthesis and antiviral activity of novel tricyclic analogues of acyclovir and ganciclovir
|
|
|
1994
|
|
S |
p. 119-
1 p.
|
artikel
|
| 216 |
65 Synthesis and properties of dioxolane deoxynucleoside analogues
|
|
|
1994
|
|
S |
p. 69-
1 p.
|
artikel
|
| 217 |
156 Synthesis and study of structural and acyclic 6-azacytidine analogues and their substituted derivates
|
|
|
1994
|
|
S |
p. 119-
1 p.
|
artikel
|
| 218 |
24 Synthesis of 2-halo- and 2-aza-adenine analogues of 1,3-oxathiolane nucleoside as potential anti-HIV agents
|
|
|
1994
|
|
S |
p. 48-
1 p.
|
artikel
|
| 219 |
25 Synthesis of novel HEPT analogues as potential anti-HIV-1 agents
|
|
|
1994
|
|
S |
p. 49-
1 p.
|
artikel
|
| 220 |
8 Synthesis of novel oxathiolane and dithiolane nucleoside analogues possessing anti-HIV activity
|
|
|
1994
|
|
S |
p. 39-
1 p.
|
artikel
|
| 221 |
181 Synthetic peptides as analogies of the adenovirus capsid protein epitopes and possible immunotherapeutical preparations
|
|
|
1994
|
|
S |
p. 132-
1 p.
|
artikel
|
| 222 |
27 Systematic SAR studies of BMS-182,193, a novel inhibitor of HIV protease
|
|
|
1994
|
|
S |
p. 50-
1 p.
|
artikel
|
| 223 |
77 The anti-influenza virus activity of a novel neuraminidase (sialidase) inhibitor 4-guanidino Neu5Ac2en
|
|
|
1994
|
|
S |
p. 77-
1 p.
|
artikel
|
| 224 |
76 The development of an antirhinovirus model based on small molecule conformations
|
|
|
1994
|
|
S |
p. 76-
1 p.
|
artikel
|
| 225 |
128 The disposition in rats and monkeys of 2-bromo-5,6-dichloro-1-(β-D-ribofuranosyl)-benzimidazole (BDCRB) and its 2,5,6-trichloro congener (TCRB)
|
|
|
1994
|
|
S |
p. 103-
1 p.
|
artikel
|
| 226 |
160 The effect of some drugs on proteolytic processing of adenoviral proteins
|
|
|
1994
|
|
S |
p. 121-
1 p.
|
artikel
|
| 227 |
161 The effect of some nucleoside analogues on reproduction of adenoviruses
|
|
|
1994
|
|
S |
p. 122-
1 p.
|
artikel
|
| 228 |
The eighth international conference on antiviral research 23 – 28 April 1995 sweeny convention center sante fe, New Mexico, USA
|
|
|
1994
|
|
S |
p. 151-
1 p.
|
artikel
|
| 229 |
169 The inhibition of flavivirus RNA synthesis by the heteropolyanion HPA-23 and related compounds in the in vitro RNA-Dependent RNA polymerase assay
|
|
|
1994
|
|
S |
p. 126-
1 p.
|
artikel
|
| 230 |
202 The new adamantane derivative inhibiting DNA-viruses reproduction
|
|
|
1994
|
|
S |
p. 142-
1 p.
|
artikel
|
| 231 |
103 The N7-isomeric acyclic nucleoside analogue 2242 is a potent and selective inhibitor of cytomegalovirus replication
|
|
|
1994
|
|
S |
p. 90-
1 p.
|
artikel
|
| 232 |
206 Theoretical foundation optimal disign criteria of antiviral preparations
|
|
|
1994
|
|
S |
p. 144-
1 p.
|
artikel
|
| 233 |
174 Therapy of patients with chronic viral infections and prophyla xy of diseases' recurrences by vaccines
|
|
|
1994
|
|
S |
p. 128-
1 p.
|
artikel
|
| 234 |
110 The safety, pharmacokinetics, and anti-CMV activity of weekly HPMPC in HIV positive patients excreting CMV
|
|
|
1994
|
|
S |
p. 94-
1 p.
|
artikel
|
| 235 |
81 The secretion of human hepatitis B virus is inhibited by the imino sugar, N-butyldeoxynojirimycin
|
|
|
1994
|
|
S |
p. 79-
1 p.
|
artikel
|
| 236 |
73 The single-dose pharmacokinetics and metabolism of 882C87, a potent anti-VZV agent with a long half-life
|
|
|
1994
|
|
S |
p. 74-
1 p.
|
artikel
|
| 237 |
187 The study of effect of a new antiviral drug arbidol on different stages of viral reproduction
|
|
|
1994
|
|
S |
p. 135-
1 p.
|
artikel
|
| 238 |
125 The tolerability and pharmacokinetics of 882C87, a potent Anti-VZV agent, after 400 mg or 800 mg oncedaily dosing for 1 week in elderly volunteers
|
|
|
1994
|
|
S |
p. 101-
1 p.
|
artikel
|
| 239 |
2 The viral fusion protein leucine-zipper, coiled-coil domain: A target for the discovery of novel antivirals
|
|
|
1994
|
|
S |
p. 36-
1 p.
|
artikel
|
| 240 |
203 Toxicity of aerosolized aprotinin in animals
|
|
|
1994
|
|
S |
p. 143-
1 p.
|
artikel
|
| 241 |
107 Treatment of murine cytomegalovirus (MCMV) infections in cell culture and in immunocompromised mice using antibodies to MCMV alone and in combination with ganciclovir (GCV) or (S)-1-(3-hydroxy-2-phosphonylmethoxypropy1)cytosine (HPMPC)
|
|
|
1994
|
|
S |
p. 92-
1 p.
|
artikel
|
| 242 |
14 Treatment of viral retinitis with high dose HPMPC liposomes
|
|
|
1994
|
|
S |
p. 42-
1 p.
|
artikel
|
| 243 |
Trends in microbicide formulations workshop
|
Friend, David R.
|
|
2010
|
|
S |
p. S1-S2
2 p.
|
artikel
|
| 244 |
23 2′,3′,5′-Trideoxyuridine-5′-methylphosphonic acid: Synthesis, antiviral evaluation, and interaction of its diphosphate derivative with hiv-1 reverse transcriptase
|
|
|
1994
|
|
S |
p. 48-
1 p.
|
artikel
|
| 245 |
115 Uracil incorporation into thymidine kinase deficient varicella-zoster virus dna
|
|
|
1994
|
|
S |
p. 96-
1 p.
|
artikel
|
| 246 |
151 Use of fluorescent tracking dye PKH26 to follow the fate of HIV-infected human PBMC in SCID mice: An In Vivo model for AIDS drug development
|
|
|
1994
|
|
S |
p. 116-
1 p.
|
artikel
|
| 247 |
54 Uveltis in prototype AIDS vaccines using SIV
|
|
|
1994
|
|
S |
p. 63-
1 p.
|
artikel
|
| 248 |
44 Zidovudine (AZT)-induced down regulation of transcripts of erythropoietin receptor (Epo-R), c-fos and β-protein kinase C (PKC) in human erythroid progenitor cells (EPC): Reversal with a combination of erythropoietin and interleukin-3
|
|
|
1994
|
|
S |
p. 58-
1 p.
|
artikel
|
Tijdschrift beschrijving